Ignite Creation Date:
2025-12-24 @ 11:24 PM
Ignite Modification Date:
2025-12-25 @ 9:10 PM
Study NCT ID:
NCT00384956
Status:
COMPLETED
Last Update Posted:
2016-12-12
First Post:
2006-10-04
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Phase II Study of Intravenous Azacitidine Alone in Patients With Myelodysplastic Syndromes
Sponsor:
Washington University School of Medicine
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-08
Start Date Type:
None
Primary Completion Date:
2008-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-03
Completion Date Type:
ACTUAL
First Submit Date:
2006-10-04
First Submit QC Date:
None
Study First Post Date:
2006-10-06
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2014-08-11
Results First Submit QC Date:
None
Results First Post Date:
2014-09-08
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-10-27
Last Update Post Date:
2016-12-12
Last Update Post Date Type:
ESTIMATED